Hyperion Defi (HYPD) Interest & Investment Income (2017 - 2026)
Hyperion Defi (HYPD) posted quarterly Interest & Investment Income of $244167.0 for Q1 2026, up 590.73% year-over-year from $35349.0 in Q1 2025, and up 75.81% quarter-over-quarter from $138878.0 in Q4 2025.
Hyperion Defi (HYPD) Interest & Investment Income (2017 - 2026) Analysis & Trends
Hyperion Defi (HYPD) has reported Interest & Investment Income for 6 consecutive years, with $244167.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Interest & Investment Income rose 590.73% year-over-year to $244167.0; the TTM figure through Mar 2026 stood at $448836.0 (up 166.48% YoY), while the FY2025 annual figure was $240018.0, down 5.51% from the prior year.
- Interest & Investment Income grew to $244167.0 in Q1 2026 per HYPD's latest filing, from $138878.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $244167.0 in Q1 2026 and bottomed at $21933.0 in Q2 2025.
- Historically, Interest & Investment Income has averaged $110778.4 across 4 years, with a median of $92902.5 in 2024.
- Annual changes were most pronounced in 2024 — Interest & Investment Income sank 88.31% — and 2026, when it jumped 590.73%.
- Hyperion Defi's Interest & Investment Income stood at $198668.0 in 2023, then tumbled by 88.31% to $23220.0 in 2024, then surged by 498.1% to $138878.0 in 2025, then surged by 75.81% to $244167.0 in 2026.
- Business Quant data shows HYPD's Interest & Investment Income at $244167.0 in Q1 2026, $138878.0 in Q4 2025, and $43858.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 48.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 67.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 27.90 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 28.14 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 115.94 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 10.98 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 5.13 Mn |
| 10 | Hyperion Defi | 44.93 Mn | 35.29 Mn | 357,693.00 | 206,764.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 206,764.00 |
| Mar 31, 2026 | 244,167.00 |
| Dec 31, 2025 | 138,878.00 |
| Sep 30, 2025 | 43,858.00 |
| Jun 30, 2025 | 21,933.00 |
| Mar 31, 2025 | 35,349.00 |
| Dec 31, 2024 | 23,220.00 |
| Sep 30, 2024 | 44,999.00 |
| Jun 30, 2024 | 64,866.00 |
| Mar 31, 2024 | 120,939.00 |
| Dec 31, 2023 | 198,668.00 |
| Sep 30, 2023 | 208,901.00 |
| Jun 30, 2023 | 183,563.00 |
| Jun 30, 2018 | 1,907.00 |
| Mar 31, 2018 | 2,137.00 |
| Jun 30, 2017 | 288.00 |
| Mar 31, 2017 | 443.00 |